Baseline iron and low-grade inflammation modulate the effectiveness of iron supplementation: evidence from follow-up of pregnant Sri Lankan women
- PMID: 32613329
- DOI: 10.1007/s00394-020-02320-2
Baseline iron and low-grade inflammation modulate the effectiveness of iron supplementation: evidence from follow-up of pregnant Sri Lankan women
Abstract
Purpose: We evaluated the effectiveness of iron supplementation in relation to baseline iron and inflammatory status of pregnant women and their offspring in Sri Lanka.
Methods: Apparently healthy women aged 18-36 years at < 12 weeks of gestation prior to receiving any supplementation were randomly recruited at the antenatal clinics. They received 60 mg of elemental iron in combined iron-folic acid pills from 12 weeks of gestation until delivery via the National Maternal Supplementation Programme. Serum ferritins (SF), hemoglobin and high-sensitive C-reactive protein (hs-CRP) were assessed. The women were grouped as iron sufficient-inflammation (+), iron sufficient-inflammation (-), iron deficient-inflammation (+) and iron deficient-inflammation (-) based on their baseline iron stores and low-grade inflammation (hs-CRP > 5 < 10 mg/L) at baseline and late pregnancy.
Results: Despite supplementation, SF in the iron sufficient-inflammation (+) women reduced significantly (p = 0.037) to deficiency state (SF < 30 µg/L) at mid-pregnancy. Whereas no significant changes were noted in the SF in iron sufficient-inflammation (-) women (p > 0.05). They maintained their stores at sufficient state until delivery. The cord SF was higher (p < 0.001) in iron sufficient-inflammation (-) than the inflammation (+) women. 96.4% of the iron deficient women remained deficient until delivery regardless of their inflammatory state. Low-grade inflammation was higher (p < 0.001) in women with baseline BMI > 25 kg/m2. Whereas inflammation at late pregnancy was higher (p < 0.001) in women who gained weight in excess of the recommended, regardless of their baseline BMI.
Conclusion: Iron status prior to supplementation and low-grade inflammation associated with BMI > 25 kg/m2 and excess weight gain during pregnancy appear to modulate the effectiveness of iron supplementation.
Keywords: Early-pregnancy iron; Iron supplementation; Low-grade inflammation; Maternal and cord serum ferritin; Newborn iron deficiency.
References
-
- World Health Organization (2012) Daily iron and folic acid supplementation in pregnant women. WHO, Geneva
-
- Ministry of Health Sri Lanka (2014) General circular—antenatal care. WHO, Geneva
-
- Atukorala TMS, De Silva LDR, Dechering WHJC et al (1994) Evaluation of effectiveness of iron-folate supplementation and anthelminthic therapy against anemia in pregnancy—a study in the plantation sector of Sri Lanka. Am J Clin Nutr 60:286–292. https://doi.org/10.1093/ajcn/60.2.286 - DOI - PubMed
-
- Siu AL (2015) Screening for iron deficiency anemia and iron supplementation in pregnant women to improve maternal health and birth outcomes: US preventive services task force recommendation statement. Ann Intern Med 163:529–536. https://doi.org/10.7326/M15-1707 - DOI - PubMed
-
- Cogswell ME, Parvanta I, Ickes L et al (2003) Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr 78:773–781 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
